MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
33.14
-0.89
-2.62%
After Hours: 33.46 +0.32 +0.97% 19:14 04/01 EDT
OPEN
33.99
PREV CLOSE
34.03
HIGH
34.93
LOW
33.01
VOLUME
2.18M
TURNOVER
--
52 WEEK HIGH
68.39
52 WEEK LOW
32.96
MARKET CAP
2.84B
P/E (TTM)
-7.6331
1D
5D
1M
3M
1Y
5Y
1D
Crispr Therapeutics call volume above normal and directionally bullish
TipRanks · 4h ago
Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.
NASDAQ · 11h ago
Cantor analysts call for RFK Jr. replacement following ousting of Marks at FDA
Seeking Alpha · 18h ago
How Peter Marks' FDA departure is impacting pharma, biotech stocks
Seeking Alpha · 1d ago
Biotech stocks slide as Marks resignation seen being negative for sector
TipRanks · 1d ago
Intellia Focuses on Pipeline Development Amid Stiff Competition
NASDAQ · 1d ago
BMO says Peter Marks resignation ‘significant negative’ for biotech
TipRanks · 1d ago
Vaccine, gene therapy makers fall after Peter Marks resignation
TipRanks · 1d ago
More
About CRSP
More
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.
Recently
Symbol
Price
%Change

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.